Pioneering Advances in Cellular Science
Driving breakthroughs in cellular technology to transform health outcomes and redefine possibilities for a better tomorrow.
Company Background

Cellcura Sciences is a regenerative medicine company headquartered in Utah.
We ethically source stem cells, growth factors, cytokines, and exosomes from donated birth tissues. These tissues come from consenting mothers after successful delivery of their child. Our regenerative products, while not FDA-approved, can be used in clinics throughout Utah.
Our ongoing technology development supports the commercialization of regenerative medicine products planned for release in late 2025.
Mission Statement
At Cellcura, our mission is to expand patient treatment options through the development of regenerative medicine therapies that support informed healthcare decisions.
We are committed to advancing evidence-based regenerative treatments and empowering both patients and healthcare providers with safe, personalized options that align with their unique needs and goals.

Products

Cellcura’s regenerative products are derived from ethically sourced birth tissues, donated after successful childbirth. These are used to create:
- Acellular regenerative medicine products
- Cellular-based therapies
Our proprietary methods are developed by an experienced team and carried out in clean room facilities located in Lehi, Utah using state-of-the-art equipment.
Please note: Cellcura’s products are not FDA approved and may only be used in the State of Utah, in accordance with Section 58-1-512 of the Utah Code (Enacted Utah Senate Bill 199) and HRC 17 guidance. Healthcare providers are responsible for ensuring regulatory compliance at all times.
Testing & Quality Guidelines
Every donor tissue undergoes rigorous screening, including medical and social history review. Each product is then tested for sterility, endotoxins, and environmental exposure either by our internal quality assurance team or a certified third-party CLIA laboratory.


Testing includes:
- USP 71 Sterility Testing – Fungus, mold, yeast, and bacteria
- Aseptic Processing Controls
- Endotoxin & environmental testing
- Screening for pathogens including (but not limited to):
HIV I/II, HBV, HCV, HTLV I/II, TSE, CJD, Treponema pallidum, WNV, CMV, Zika, Lyme disease, Epstein-Barr, Candida, E. coli, and COVID-19.
For a complete list of testing, please contact your Cellcura representative.